Additionally, GLP-1 Semaglutide slows stomach emptying, keeping food in the stomach longer
Preclinical Study Summary Ipamorelin has been investigated in multiple preclinical contexts including neuroendocrine research, bone density studies in ovariectomized rat models, and gastrointestinal motility research
10.1111/dom.13761 Summary Keywords anti-inflammatory, atherosclerosis, coronary artery disease, glucagon-like peptide-1, mechanisms Citation Skrobucha A, Pindlowski P, Krajewska N, Grabowski M and Jonik S (2024) Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review
Nutrition Metabolism, 13, 16
For physicians that treat it and their patients, understanding how a therapy alters BMR is essential for selecting optimal regimens and monitoring outcomes
The CVOT results for the oral version of semaglutide (Rybelsus) are pending, with results expected soon